Presentation
Rare malignant ovarian/gynaecological tumours at a locally advanced or metastatic stage.
Criteria before considering a discussion in MDM-FMG
- Patient with a rare malignant gynaecological tumour, reviewed by an expert pathologist from TMRG
- Estimated life expectancy > 3 months
- Not eligible for inclusion in a dedicated molecular screening programme
Genome Sequencing in diagnostic strategy
MDM cartography
AP-HP / Institut Curie / Diaconesses / Croix Saint-Simon
Centre Jean Perrin
Christophe POMEL
Centre Oscar Lambret
S. BECOURT
S. MAKHLOUFI (suppléante)
C. ABDEDDAIM (suppléant)
F. NARDUCCI (suppléant)
Institut de Cancérologie de l’Ouest
Dominique BERTON
MDM cartography
MDM FMG Solid tumors adults AP-HP Paris
Camille TLEMSANI
MDM FMG Solid tumors adults Curie Paris
MDM Coordination team
MDM FMG Solid tumors adults Gustave Roussy Villejuif
Claudio NICOTRA
MDM FMG Solid Tumors adults Rennes
Thierry LESIMPLE
Julien EDELINE
Thibault DE LA MOTTE ROUGE
Thierry FEST
Alexandra LESPAGNOL
Florian ESTRADE
MDM FMG Solid tumors adults Brest
MDM FMG Solid tumors adults Angers
MDM FMG Solid tumors adults Nantes
MDM FMG Solid tumors adults Tours
Arnaud ROMOLI
MDM FMG Solid tumors adults Caen
MDM FMG Solid Tumors adults Amiens
Bruno CHAUFFERT
Claire POULET
Julie DREMAUX
MDM FMG Solid tumors adults Lille
MDM FMG Solid tumors adults Strasbourg
Philippe BARTHELEMY
MDM FMG Solid tumors adults Nancy
Dr Jean-Marie RAVEL
Dr Laëtitia LAMBERT
Dr Ludovic MANSUY
MDM FMG Solid tumors adults Dijon
François GHIRINGHELLI
MDM FMG Solid tumors adults CLB Lyon
Olivier TREDAN
MDM FMG Solid tumors adults CITOHL Lyon
Benoît YOU
MDM FMG Solid tumors adults APHM Marseille
Pascale TOMASINI
MDM FMG Solid tumors adults IPC Marseille
François BERTUCCI
MDM FMG Solid tumors adults Montpellier
Stanislas QUESADA
MDM FMG Solid tumors adults Nice
Esma SAADA-BOUZID
MDM FMG Solid tumors adults Toulouse
MDM FMG Solid tumors adults Bergonié Bordeaux
Pr Jean-Philippe MERLIO
MDM FMG Solid tumors adults CHU Poitiers
Camille EVRARD